Instrument Inactif

Communiqués InVitro International Other OTC

Actions

05/05	Continuing the Cause; Humane Global Animal Welfare	NE
11/02	InVitro International & the World's Animals Look Forward to 2026	NE
09/12	Game Changing Signals from Global Regulatory Agencies Accompany IVRO Sales and Profit Gains	NE
05/08/25	IVRO's Q3 Packed with Positives; Sales, Profits, and U.S. Government/Global Support for Animal Welfare	NE
13/05/25	IVRO Continues Drive to Minimize Unnecessary Live Animal Testing	AQ
04/02/25	IVRO Announces Strong FY '25 First Quarter Sales & Net Income Advances	NE
14/01/25	IVRO Signs MOU to Merge With a European Based Non-Animal Testing Focused Organization	NE
04/12/24	InVitro International: Expectations Remain High for Animal Welfare & Growth Opportunities	NE
03/09/24	InVitro International Engages Askew Kabala and Company, Inc. to Further Advance Its Corporate Growth Plan	NE
31/07/24	InVitro International Progresses with Growth Strategies and Continues Profitability	NE
02/05/24	InVitro International Reports Positive First Half and Second Quarter FY '24 Results; Also Planning an OTC Markets Uplisting	NE
14/02/24	InVitro International Sees Real Positives in Start to FY '24	NE
13/11/23	InVitro International Announces Fiscal Year End 2023 and Continues Positives	NE